RU2001129362A - COMPOSITION INCLUDING UNDECANOATE TESTOSTERONE AND CASTOR BUTTER - Google Patents
COMPOSITION INCLUDING UNDECANOATE TESTOSTERONE AND CASTOR BUTTERInfo
- Publication number
- RU2001129362A RU2001129362A RU2001129362/14A RU2001129362A RU2001129362A RU 2001129362 A RU2001129362 A RU 2001129362A RU 2001129362/14 A RU2001129362/14 A RU 2001129362/14A RU 2001129362 A RU2001129362 A RU 2001129362A RU 2001129362 A RU2001129362 A RU 2001129362A
- Authority
- RU
- Russia
- Prior art keywords
- liquid carrier
- testosterone undecanoate
- pharmaceutical composition
- dissolved
- castor oil
- Prior art date
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 title 2
- 229960003604 Testosterone Drugs 0.000 title 1
- ZDPHROOEEOARMN-UHFFFAOYSA-M undecanoate Chemical compound CCCCCCCCCCC([O-])=O ZDPHROOEEOARMN-UHFFFAOYSA-M 0.000 title 1
- 239000000969 carrier Substances 0.000 claims 8
- UDSFVOAUHKGBEK-CNQKSJKFSA-N [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] undecanoate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCCCCCCCC)[C@@]1(C)CC2 UDSFVOAUHKGBEK-CNQKSJKFSA-N 0.000 claims 7
- 239000007788 liquid Substances 0.000 claims 7
- 229960000746 testosterone undecanoate Drugs 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 239000004359 castor oil Substances 0.000 claims 4
- 235000019438 castor oil Nutrition 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- 229940100688 Oral Solution Drugs 0.000 claims 1
- 239000003098 androgen Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
Claims (8)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99302581 | 1999-04-01 | ||
EP99302581.6 | 1999-04-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001129362A true RU2001129362A (en) | 2003-08-27 |
RU2246296C2 RU2246296C2 (en) | 2005-02-20 |
Family
ID=8241306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001129362/15A RU2246296C2 (en) | 1999-04-01 | 2000-03-27 | Composition comprising testosterone undecanoate and castor oil |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1189620B1 (en) |
JP (1) | JP2002541111A (en) |
KR (1) | KR100666016B1 (en) |
CN (1) | CN1155385C (en) |
AT (1) | ATE269708T1 (en) |
AU (1) | AU768537B2 (en) |
BR (1) | BR0009465A (en) |
CA (1) | CA2366856C (en) |
CZ (1) | CZ298573B6 (en) |
DE (1) | DE60011771T2 (en) |
DK (1) | DK1189620T3 (en) |
ES (1) | ES2222199T3 (en) |
HK (1) | HK1043544A1 (en) |
HU (1) | HU229455B1 (en) |
ID (1) | ID30481A (en) |
IL (2) | IL145524A0 (en) |
MX (1) | MXPA01009919A (en) |
NO (1) | NO329420B1 (en) |
NZ (1) | NZ514290A (en) |
PL (1) | PL195163B1 (en) |
PT (1) | PT1189620E (en) |
RU (1) | RU2246296C2 (en) |
SK (1) | SK286071B6 (en) |
TR (1) | TR200102769T2 (en) |
TW (1) | TWI280124B (en) |
WO (1) | WO2000059512A1 (en) |
ZA (1) | ZA200107781B (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6652880B1 (en) | 1999-04-01 | 2003-11-25 | R.P. Scherer Technologies, Inc. | Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants |
GB9907715D0 (en) * | 1999-04-01 | 1999-05-26 | Scherer Corp R P | Pharmaceutical compositions |
JO2505B1 (en) * | 2003-03-14 | 2009-10-05 | باير شيرنغ فارما اكتنجيسيلشافت | method and pharmaceutical compositions for reliable achievements of acceptable serum testosterone levels |
DK1530965T3 (en) * | 2003-11-11 | 2006-07-17 | Mattern Udo | Controlled release delivery system for nasal application |
US8784869B2 (en) | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and methods of treatment |
US20060140820A1 (en) | 2004-12-28 | 2006-06-29 | Udo Mattern | Use of a container of an inorganic additive containing plastic material |
KR20080009201A (en) | 2005-04-15 | 2008-01-25 | 클라루스 쎄러퓨틱스, 아이엔씨. | Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
US8492369B2 (en) | 2010-04-12 | 2013-07-23 | Clarus Therapeutics Inc | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
CN101600417B (en) | 2006-10-04 | 2012-05-30 | M&P专利股份公司 | Controlled release delivery system for nasal application of neurotransmitters |
GB0818473D0 (en) | 2008-10-08 | 2008-11-12 | Probio Nutraceuticals As | Composition |
US11304960B2 (en) * | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
ES2525520T3 (en) * | 2010-04-12 | 2014-12-26 | Clarus Therapeutics, Inc. | Oral testosterone ester formulations and methods to treat testosterone deficiency with them |
GB201006200D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
UA114705C2 (en) * | 2011-01-26 | 2017-07-25 | Аллерган, Інк. | Androgen composition for treating an opthalmic condition |
US20130040923A1 (en) | 2011-05-13 | 2013-02-14 | Trimel Pharmaceuticals Corporation | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
WO2015193224A1 (en) | 2014-06-17 | 2015-12-23 | Merck Sharp & Dohme B.V. | Stable formulations of testosterone undecanoate |
JP6723166B2 (en) * | 2014-06-19 | 2020-07-15 | ソルラル ファーマ エーピーエス | Solid oral dosage form of lipophilic compound |
WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
RU2017111503A (en) * | 2014-08-29 | 2018-10-05 | Липосин Инк. | COMPOSITIONS (17-β) -3-OXOANDROST-4-EN-17-IL UNDECANOATE AND METHODS FOR PRODUCING AND USING THEM |
CA3078723A1 (en) | 2016-11-28 | 2018-05-31 | Nachiappan Chidambaram | Oral testosterone undecanoate therapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1102095A (en) * | 1993-10-30 | 1995-05-03 | 浙江医科大学 | Long-acting androgen preparation-undecylic acid testis injection |
GB9608719D0 (en) * | 1996-04-26 | 1996-07-03 | Scherer Ltd R P | Pharmaceutical compositions |
SE9700642D0 (en) * | 1997-02-24 | 1997-02-24 | Kronvall Stefan Med Ab | Means and ways of preventing and treating the metabolic syndrome |
-
2000
- 2000-03-27 WO PCT/EP2000/002677 patent/WO2000059512A1/en active IP Right Grant
- 2000-03-27 MX MXPA01009919A patent/MXPA01009919A/en active IP Right Grant
- 2000-03-27 DE DE60011771T patent/DE60011771T2/en not_active Expired - Lifetime
- 2000-03-27 CN CNB008059381A patent/CN1155385C/en not_active Expired - Lifetime
- 2000-03-27 EP EP00920588A patent/EP1189620B1/en not_active Expired - Lifetime
- 2000-03-27 CZ CZ20013507A patent/CZ298573B6/en not_active IP Right Cessation
- 2000-03-27 CA CA002366856A patent/CA2366856C/en not_active Expired - Lifetime
- 2000-03-27 HU HU0200453A patent/HU229455B1/en unknown
- 2000-03-27 AT AT00920588T patent/ATE269708T1/en active
- 2000-03-27 DK DK00920588T patent/DK1189620T3/en active
- 2000-03-27 IL IL14552400A patent/IL145524A0/en active IP Right Grant
- 2000-03-27 RU RU2001129362/15A patent/RU2246296C2/en active
- 2000-03-27 BR BR0009465-0A patent/BR0009465A/en not_active Application Discontinuation
- 2000-03-27 SK SK1372-2001A patent/SK286071B6/en not_active IP Right Cessation
- 2000-03-27 KR KR1020017012498A patent/KR100666016B1/en active IP Right Grant
- 2000-03-27 JP JP2000609075A patent/JP2002541111A/en not_active Withdrawn
- 2000-03-27 AU AU41111/00A patent/AU768537B2/en not_active Expired
- 2000-03-27 PL PL00351259A patent/PL195163B1/en unknown
- 2000-03-27 PT PT00920588T patent/PT1189620E/en unknown
- 2000-03-27 ES ES00920588T patent/ES2222199T3/en not_active Expired - Lifetime
- 2000-03-27 TR TR2001/02769T patent/TR200102769T2/en unknown
- 2000-03-27 NZ NZ514290A patent/NZ514290A/en not_active IP Right Cessation
- 2000-03-27 ID IDW00200102082A patent/ID30481A/en unknown
- 2000-05-11 TW TW089109036A patent/TWI280124B/en not_active IP Right Cessation
-
2001
- 2001-09-20 ZA ZA200107781A patent/ZA200107781B/en unknown
- 2001-09-20 IL IL145524A patent/IL145524A/en not_active IP Right Cessation
- 2001-09-28 NO NO20014718A patent/NO329420B1/en not_active IP Right Cessation
-
2002
- 2002-07-17 HK HK02105288A patent/HK1043544A1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2001129362A (en) | COMPOSITION INCLUDING UNDECANOATE TESTOSTERONE AND CASTOR BUTTER | |
ATE269708T1 (en) | FORMULATION CONTAINING TESTOSTEONUNDECANOATE AND CASCIN OIL | |
DK2600851T3 (en) | PHARMACEUTICAL DOSAGE FORM CONTAINING 6'-FLUORO- (N-METHYL OR N, N-DIMETHYL -) - 4-PHENYL-4 ', 9'-DIHYDRO-3'H-SPIRO [CYCLOHEXAN-1,1'-PYRANO [3,4, B] INDOL] -4-AMINE FOR TREATMENT OF NEUROPATHIC PAIN | |
AU2006324219B2 (en) | Butylphthalide intravenous emulsion and application thereof | |
US20040110828A1 (en) | Tetrahydrocannabinol compositions and methods of manufacture and use thereof | |
CA2185347A1 (en) | A carrier for hydrophobic drugs and a pharmaceutical composition based thereon | |
JP2010235636A (en) | Pharmaceutical formulation of taxanes | |
JP5052558B2 (en) | Gel ointment | |
GB9907715D0 (en) | Pharmaceutical compositions | |
BRPI0008228B1 (en) | pharmaceutical composition containing n-benzoyl staurosporine and solubilizing agents | |
AU703842B2 (en) | Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders | |
NZ539046A (en) | Chemotherapeutic self-emulsifying microemulsion compositions of paclitaxel with improved oral bioavailability | |
CA1249223A (en) | Solid drug formulations and stable suspensions | |
JP5435659B2 (en) | Formulation form for oral mucosal administration of triptan | |
RU2216342C2 (en) | Cyclosporin solution | |
JP2006509785A (en) | Oral microemulsion composition of biphenyldimethyldicarboxylic acid | |
WO2007147371A2 (en) | Pharmaceutical composition for oral administration | |
JPH044300B2 (en) | ||
US20230089681A1 (en) | Use of a combination of sulficant compounds with a liquid carrier as a self emulsifying drug delivery system | |
AU745008B2 (en) | Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors | |
JP3748912B2 (en) | High concentration solution formulation of aureobasidins | |
US20060024341A1 (en) | Microemulsion composition and related method | |
KR20050030282A (en) | Formulation and manufacturing process solubilized simvastatin soft capsules | |
RU2642244C2 (en) | Oral pharmaceutical compositions of testosterone esters and method for testosterone shortage treatment with their use | |
RU95119385A (en) | PHARMACEUTICAL COMPOSITION CONTAINING LIPOPHILIC MEDICINES |